Physician profile
Mark A Luff
NPI 1902993454
$485.86
in general payments reported to CMS, 2019-2025
17 companies · $93.60 in 2025
The $93.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.43 · 2021: $136 · 2022: $90.12 · 2023: $17.39 · 2024: $96.37 · 2025: $93.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $97.31 | 2024-2025 | |
| Lilly USA, LLC | $73.87 | 2019-2024 | Zepbound, Mounjaro |
| Novo Nordisk INC | $68.20 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $38.09 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.28 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $17.39 | 2023 | Farxiga |
| Amgen INC. | $16.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.15 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.38 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $14.80 | 2025 | Rexulti |
| Mylan Specialty L.P. | $14.73 | 2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $14.22 | 2021 | |
| Eisai INC. | $13.19 | 2021 | |
| Allergan, INC. | $13.18 | 2019 | |
| Glaxosmithkline, LLC. | $12.02 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $11.93 | 2021 | |
| Daiichi Sankyo INC. | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Luff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.